Literature DB >> 22186675

Orbitofrontal connectivity with resting-state networks is associated with midbrain dopamine D3 receptor availability.

David M Cole1, Christian F Beckmann, Graham E Searle, Christophe Plisson, Andri C Tziortzi, Thomas E Nichols, Roger N Gunn, Paul M Matthews, Eugenii A Rabiner, John D Beaver.   

Abstract

Animal research and human postmortem evidence highlight the importance of brain dopamine D3 receptor (D3R) function in multiple neuropsychiatric disorders, including addiction. Separate anatomical and functional neuroimaging findings implicate disrupted frontal cortical connectivity with distributed brain networks in processes relevant for these diseases. This potential conjunction between molecular and functional markers has not, however, been tested directly. Here, we used a novel combination of [(11)C]-(+)-PHNO positron emission tomography and resting-state functional magnetic resonance imaging in the same healthy individuals to investigate whether differences in midbrain D3R availability are associated with functional interactions between large-scale networks and regions involved in reward processing and cognition. High midbrain D3R availability was associated with reduced functional connectivity between orbitofrontal cortex (OFC) and networks implicated in cognitive control and salience processing. The opposite pattern was observed in subcortical reward circuitry and the "default mode" network, which showed greater connectivity with OFC in individuals with high D3R availability. These findings demonstrate that differential interactions between OFC and networks implicated in cognitive control and reward are associated with midbrain D3R availability, consistent with the hypothesis that dopamine D3R signaling is an important molecular pathway underlying goal-directed behavior.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22186675     DOI: 10.1093/cercor/bhr354

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  39 in total

Review 1.  Molecular imaging and neural networks in impulse control disorders in Parkinson's disease.

Authors:  I Aracil-Bolaños; A P Strafella
Journal:  Parkinsonism Relat Disord       Date:  2015-08-12       Impact factor: 4.891

2.  Acute and long-term effects of adolescent methylphenidate on decision-making and dopamine receptor mRNA expression in the orbitofrontal cortex.

Authors:  Leslie R Amodeo; Eliza Jacobs-Brichford; Matthew S McMurray; Jamie D Roitman
Journal:  Behav Brain Res       Date:  2017-02-14       Impact factor: 3.332

3.  Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients.

Authors:  Giacomo Koch; Francesco Di Lorenzo; Sonia Bonnì; Viola Giacobbe; Marco Bozzali; Carlo Caltagirone; Alessandro Martorana
Journal:  Neuropsychopharmacology       Date:  2014-05-26       Impact factor: 7.853

4.  Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO.

Authors:  Doris E Payer; Arian Behzadi; Stephen J Kish; Sylvain Houle; Alan A Wilson; Pablo M Rusjan; Junchao Tong; Peter Selby; Tony P George; Tina McCluskey; Isabelle Boileau
Journal:  Neuropsychopharmacology       Date:  2013-08-07       Impact factor: 7.853

5.  mRNA expression of dopamine receptors in peripheral blood lymphocytes of computer game addicts.

Authors:  Nasim Vousooghi; Seyed Zeinolabedin Zarei; Mitra-Sadat Sadat-Shirazi; Fatemeh Eghbali; Mohammad Reza Zarrindast
Journal:  J Neural Transm (Vienna)       Date:  2015-05-14       Impact factor: 3.575

6.  Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's disease.

Authors:  Paula Trujillo; Nelleke C van Wouwe; Ya-Chen Lin; Adam J Stark; Kalen J Petersen; Hakmook Kang; David H Zald; Manus J Donahue; Daniel O Claassen
Journal:  Cortex       Date:  2019-01-29       Impact factor: 4.027

Review 7.  Phenotypic variability in resting-state functional connectivity: current status.

Authors:  Chandan J Vaidya; Evan M Gordon
Journal:  Brain Connect       Date:  2013

Review 8.  Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherapeutic management of substance use disorders.

Authors:  Christian Heidbreder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-28       Impact factor: 3.000

Review 9.  The potential role of dopamine D₃ receptor neurotransmission in cognition.

Authors:  Shinichiro Nakajima; Philip Gerretsen; Hiroyoshi Takeuchi; Fernando Caravaggio; Tiffany Chow; Bernard Le Foll; Benoit Mulsant; Bruce Pollock; Ariel Graff-Guerrero
Journal:  Eur Neuropsychopharmacol       Date:  2013-06-20       Impact factor: 4.600

10.  Functional connectivity of substantia nigra and ventral tegmental area: maturation during adolescence and effects of ADHD.

Authors:  Dardo Tomasi; Nora D Volkow
Journal:  Cereb Cortex       Date:  2012-12-12       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.